Mad Cow Disease. An Opportunity for Preventive Medicine?

Overview

Journal West J Med

Specialty General Medicine

Date 1998 Jan 14

PMID 9426481

Authors

P SALZMANN

S Saint

L M Tierney Jr

Affiliations

Soon will be listed here.

References

Detsky A, Naglie I . A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990; 113(2):147-54. DOI: 10.7326/0003-4819-113-2-147. View

Brown P . The risk of bovine spongiform encephalopathy ('mad cow disease') to human health. JAMA. 1997; 278(12):1008-11. View

Goldman L, Gordon D, Rifkind B, Hulley S, Detsky A, Goodman D . Cost and health implications of cholesterol lowering. Circulation. 1992; 85(5):1960-8. DOI: 10.1161/01.cir.85.5.1960. View

Pauker S . Deciding about screening. Ann Intern Med. 1993; 118(11):901-2. DOI: 10.7326/0003-4819-118-11-199306010-00013. View

Kimberlin R, Wilesmith J . Bovine spongiform encephalopathy. Epidemiology, low dose exposure and risks. Ann N Y Acad Sci. 1994; 724:210-20. DOI: 10.1111/j.1749-6632.1994.tb38911.x. View

Wilesmith J . An epidemiologist's view of bovine spongiform encephalopathy. Philos Trans R Soc Lond B Biol Sci. 1994; 343(1306):357-61. DOI: 10.1098/rstb.1994.0029. View

Holman R, Khan A, Kent J, Strine T, Schonberger L . Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology. 1995; 14(4):174-81. DOI: 10.1159/000109793. View

Gage B, Cardinalli A, Albers G, Owens D . Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995; 274(23):1839-45. View

Will R, Ironside J, Zeidler M, Cousens S, Estibeiro K, Alperovitch A . A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996; 347(9006):921-5. DOI: 10.1016/s0140-6736(96)91412-9. View

10.

Marwick C . Views of reason for mad cow disease vary widely. JAMA. 1996; 276(6):438-40. View

11.

Russell L, Gold M, Siegel J, Daniels N, Weinstein M . The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996; 276(14):1172-7. View

12.

. Bovine spongiform encephalopathy: "mad cow disease". Nutr Rev. 1996; 54(7):208-10. DOI: 10.1111/j.1753-4887.1996.tb03934.x. View

13.

Beardsley T . Deadly enigma. The U.S. wakes up to the threat of mad cow disease and its relatives. Sci Am. 1996; 275(6):16-8. View

14.

Holman R, Khan A, Belay E, Schonberger L . Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis. 1996; 2(4):333-7. PMC: 2639929. DOI: 10.3201/eid0204.960409. View

15.

Goldman L, Weinstein M, Goldman P, Williams L . Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991; 265(9):1145-51. View